Roche has significantly expanded its AI infrastructure with 2,176 new NVIDIA Blackwell GPUs, creating the largest announced hybrid-cloud AI factory in the pharmaceutical industry. This addition brings Roche's total GPU count to over 3,500, supporting its goal of an AI-accelerated healthcare organization. This investment builds upon a strategic collaboration with NVIDIA to advance drug development and improve healthcare outcomes. The AI factory integrates AI across the entire value chain, from research and development to manufacturing and commercialization. Roche utilizes NVIDIA's BioNeMo platform for research acceleration and insights. Digital twins built with NVIDIA Omniverse optimize manufacturing processes. The company also employs accelerated computing for diagnostics and digital pathology, improving image analysis. Roche uses NVIDIA NeMo Guardrails to ensure safe and reliable healthcare-grade conversational AI. This expansion strengthens Roche's leadership in AI-driven drug discovery and development. The initiative aims to shorten the path from scientific insights to life-saving medicines. This AI factory investment is a cornerstone of Roche's broader digital transformation.